RAINBOW.NS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 18:00):

Stats
今日成交量	2.23M
平均成交量	278 866
市值	159.49B
EPS	INR6.20 ( 2023-10-30 )
Last Dividend	INR3.00 ( 2023-06-22 )
Next Dividend	INR0 ( N/A )
P/E	72.51
ATR14	INR4.12 (0.26%)

音量相关性

長: -0.40 (neutral)

短: 0.46 (neutral)

Signal:(67.134) Neutral

Rainbow Children's 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Rainbow Children's 相关性 - 货币/商品

-0.57
( weak negative )

-0.69
( moderate negative )

-0.62
( weak negative )

-0.48
( neutral )

-0.23
( neutral )

-0.19
( neutral )

Rainbow Children's 财务报表

Annual	2022
营收:	INR11.74B
毛利润:	INR10.15B (86.51 %)
EPS:	INR20.89

FY	2022
营收:	INR11.74B
毛利润:	INR10.15B (86.51 %)
EPS:	INR20.89

FY	2022
营收:	INR9.74B
毛利润:	INR7.79B (80.00 %)
EPS:	INR13.62

FY	2021
营收:	INR6.40B
毛利润:	INR5.37B (83.86 %)
EPS:	INR3.90

Financial Reports:

No articles found.

Rainbow Children's Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR2.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Rainbow Children's Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.46 - low (48.13%) | Divividend Growth Potential Score: 4.43 - Stable (11.43%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR2.00	2022-09-07
Last Dividend	INR3.00	2023-06-22
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	INR5.00	--
Avg. Dividend % Per Year	0.21%	--
Score	1.94	--
Div. Sustainability Score	4.46
Div.Growth Potential Score	4.43
Div. Directional Score	4.44	--

Next Divdend (Est)
(2024-09-30)

INR3.67 Estimate 3.00 %

Dividend Stability

0.24 Very Poor

Dividend Score

1.94

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2022	INR2.00	0.44%
2023	INR3.00	0.40%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SPAL.NS	Dividend Junior	2023-09-15	Sporadic	8	0.44%
MOTHERSON.NS	Dividend Junior	2023-08-11	Annually	23	0.63%
HERITGFOOD.NS	Dividend Junior	2023-08-14	Annually	23	0.44%
BIKAJI.NS	Dividend Junior	2023-06-08	Insufficient data to determine frequency	2	0.06%
RANEHOLDIN.NS	Dividend Junior	2023-07-27	Annually	21	0.95%
KOPRAN.NS	Dividend Junior	2023-09-07	Annually	5	1.18%
ESCORTS.NS	Dividend Junior	2023-06-30	Annually	28	0.21%
ALPHAGEO.NS	Dividend Junior	2023-09-22	Annually	18	2.07%
SYMPHONY.NS	Dividend Knight	2023-08-04	Semi-Annually	14	0.47%
NESCO.NS	Dividend Junior	2023-07-28	Annually	17	0.40%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.173	1.500	6.55	9.82	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.199	1.500	8.90	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6.12	1.000	8.85	8.85	[3 - 30]
operatingCashFlowPerShareTTM	20.20	2.00	3.27	6.53	[0 - 30]
freeCashFlowPerShareTTM	20.20	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.870	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.270	1.000	6.59	6.59	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.46

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	74.32	1.000	2.59	0	[1 - 100]
returnOnEquityTTM	0.199	2.50	9.29	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	20.20	2.00	3.27	10.00	[0 - 30]
dividendYielPercentageTTM	0.187	1.500	5.34	0	[0 - 0.4]
operatingCashFlowPerShareTTM	20.20	2.00	3.27	6.53	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.785	1.500	1.431	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.161	1.000	8.47	0	[0.1 - 0.5]
Total Score				4.43

Rainbow Children's

Rainbow Children's Medicare Limited operates a multi-specialty pediatric and obstetrics, and gynecology hospital chain in India. The company's child health services include general pediatrics, neonatalogy, surgery, gastroenterology and liver diseases, hematology and oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, psychiatry, ENT, cardiology, radiology, physiotherapy and rehabilitation, orthopedics, urology, ophthalmology, dermatology, allergy, neurosurgery, rheumatology, infectious disease, and cranio-maxillofacial surgery; intensive care unit, bone marrow transplant unit, anesthesia and pain management, kidney transplant, cochlear implant services; genetics and metabolic medicines; and laboratory, speech and language therapy, occupational therapy, pediatric and metabolic medicine, developmental and behavioral pediatrics, cerebral palsy care services. Its women health services include obstetrics and gynecology, painless delivery and labor, high risk pregnancy, pregnancy and delivery, childbirth preparation classes, vaginal birth after cesarean, breast feeding support, well women checkup, urogynecology, pre-pregnancy health checkup, minimally invasive surgery, breast care, fetal medicine, menopausal treatment, new-born care, women's nutrition, and diabetology. The company also provides fertility care services, such as fertility treatment, ovulation induction, intracytoplasmic sperm injection treatment, investigation, intrauterine insemination, intracytoplasmic morphologically selected sperm injection, assisted hatching, cryopreservation, sperm and oocyte donor treatments, frozen embryo transfer, surgical sperm retrieval, embryo donor treatments, reproductive surgery, pre-conception counselling, and andrology and urology. As of December 31, 2021, it operated 14 hospitals and 3 clinics in 6 cities with a total of 1,500 beds. The company was incorporated in 1998 and is based in Hyderabad, India.